BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pacheco AR, Sperandio V. Shiga toxin in enterohemorrhagic E.coli: regulation and novel anti-virulence strategies. Front Cell Infect Microbiol 2012;2:81. [PMID: 22919672 DOI: 10.3389/fcimb.2012.00081] [Cited by in Crossref: 73] [Cited by in F6Publishing: 67] [Article Influence: 7.3] [Reference Citation Analysis]
Number Citing Articles
1 Kuo CJ, Chen JW, Chiu HC, Teng CH, Hsu TI, Lu PJ, Syu WJ, Wang ST, Chou TC, Chen CS. Mutation of the Enterohemorrhagic Escherichia coli Core LPS Biosynthesis Enzyme RfaD Confers Hypersusceptibility to Host Intestinal Innate Immunity In vivo. Front Cell Infect Microbiol 2016;6:82. [PMID: 27570746 DOI: 10.3389/fcimb.2016.00082] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.2] [Reference Citation Analysis]
2 To CZ, Bhunia AK. Three Dimensional Vero Cell-Platform for Rapid and Sensitive Screening of Shiga-Toxin Producing Escherichia coli. Front Microbiol 2019;10:949. [PMID: 31134009 DOI: 10.3389/fmicb.2019.00949] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
3 Munir S, Shah AA, Shahid M, Manzoor I, Aslam B, Rasool MH, Saeed M, Ayaz S, Khurshid M. Quorum Sensing Interfering Strategies and Their Implications in the Management of Biofilm-Associated Bacterial Infections. Braz arch biol technol 2020;63:e20190555. [DOI: 10.1590/1678-4324-2020190555] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
4 Maddocks SE. Novel Targets of Antimicrobial Therapies. Microbiol Spectr 2016;4. [PMID: 27227296 DOI: 10.1128/microbiolspec.VMBF-0018-2015] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.8] [Reference Citation Analysis]
5 Munekata PES, Pateiro M, Rodríguez-Lázaro D, Domínguez R, Zhong J, Lorenzo JM. The Role of Essential Oils against Pathogenic Escherichia coli in Food Products. Microorganisms 2020;8:E924. [PMID: 32570954 DOI: 10.3390/microorganisms8060924] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
6 García-Angulo VA, Kalita A, Kalita M, Lozano L, Torres AG. Comparative genomics and immunoinformatics approach for the identification of vaccine candidates for enterohemorrhagic Escherichia coli O157:H7. Infect Immun 2014;82:2016-26. [PMID: 24595137 DOI: 10.1128/IAI.01437-13] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
7 Park H, Lee K, Yeo S, Shin H, Holzapfel WH. Autoinducer-2 Quorum Sensing Influences Viability of Escherichia coli O157:H7 under Osmotic and In Vitro Gastrointestinal Stress Conditions. Front Microbiol 2017;8:1077. [PMID: 28659895 DOI: 10.3389/fmicb.2017.01077] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 2.6] [Reference Citation Analysis]
8 Bhunia AK. Escherichia coli. Foodborne Microbial Pathogens. New York: Springer; 2018. pp. 249-69. [DOI: 10.1007/978-1-4939-7349-1_14] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 McHugh RE, O'Boyle N, Connolly JPR, Hoskisson PA, Roe AJ. Characterization of the Mode of Action of Aurodox, a Type III Secretion System Inhibitor from Streptomyces goldiniensis. Infect Immun 2019;87:e00595-18. [PMID: 30455200 DOI: 10.1128/IAI.00595-18] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
10 Gray MD, Lampel KA, Strockbine NA, Fernandez RE, Melton-Celsa AR, Maurelli AT. Clinical isolates of Shiga toxin 1a-producing Shigella flexneri with an epidemiological link to recent travel to Hispañiola. Emerg Infect Dis 2014;20:1669-77. [PMID: 25271406 DOI: 10.3201/eid2010.140292] [Cited by in Crossref: 39] [Cited by in F6Publishing: 30] [Article Influence: 5.6] [Reference Citation Analysis]
11 Barnett Foster D. Modulation of the enterohemorrhagic E. coli virulence program through the human gastrointestinal tract. Virulence 2013;4:315-23. [PMID: 23552827 DOI: 10.4161/viru.24318] [Cited by in Crossref: 46] [Cited by in F6Publishing: 35] [Article Influence: 5.1] [Reference Citation Analysis]
12 Pacheco AR, Barile D, Underwood MA, Mills DA. The impact of the milk glycobiome on the neonate gut microbiota. Annu Rev Anim Biosci 2015;3:419-45. [PMID: 25387230 DOI: 10.1146/annurev-animal-022114-111112] [Cited by in Crossref: 104] [Cited by in F6Publishing: 94] [Article Influence: 13.0] [Reference Citation Analysis]
13 Fu M, Liang S, Wu J, Hua Y, Chen H, Zhang Z, Liu J, Li X, Zhang B, Zhao W, Wan C. An Escherichia coli Effector Protein EspF May Induce Host DNA Damage via Interaction With SMC1. Front Microbiol 2021;12:682064. [PMID: 34122393 DOI: 10.3389/fmicb.2021.682064] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Tabaran A, Soulageon V, Chirila F, Reget OL, Mihaiu M, Borzan M, Dan SD. Pathogenic E. coli from Cattle as a Reservoir of Resistance Genes to Various Groups of Antibiotics. Antibiotics 2022;11:404. [DOI: 10.3390/antibiotics11030404] [Reference Citation Analysis]
15 In J, Foulke-Abel J, Zachos NC, Hansen AM, Kaper JB, Bernstein HD, Halushka M, Blutt S, Estes MK, Donowitz M, Kovbasnjuk O. Enterohemorrhagic <i>Escherichia coli</i> reduce mucus and intermicrovillar bridges in human stem cell-derived colonoids. Cell Mol Gastroenterol Hepatol. 2016;2:48-62.e3. [PMID: 26855967 DOI: 10.1016/j.jcmgh.2015.10.001] [Cited by in Crossref: 127] [Cited by in F6Publishing: 120] [Article Influence: 21.2] [Reference Citation Analysis]
16 Romeo L, Iori R, Rollin P, Bramanti P, Mazzon E. Isothiocyanates: An Overview of Their Antimicrobial Activity against Human Infections. Molecules 2018;23:E624. [PMID: 29522501 DOI: 10.3390/molecules23030624] [Cited by in Crossref: 58] [Cited by in F6Publishing: 44] [Article Influence: 14.5] [Reference Citation Analysis]
17 Runte CS, Jain U, Getz LJ, Secord S, Kuwae A, Abe A, LeBlanc JJ, Stadnyk AW, Kaper JB, Hansen AM, Thomas NA. Tandem tyrosine phosphosites in the Enteropathogenic Escherichia coli chaperone CesT are required for differential type III effector translocation and virulence. Mol Microbiol 2018;108:536-50. [PMID: 29509331 DOI: 10.1111/mmi.13948] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
18 Nebbia S, Lamberti C, Lo Bianco G, Cirrincione S, Laroute V, Cocaign-Bousquet M, Cavallarin L, Giuffrida MG, Pessione E. Antimicrobial Potential of Food Lactic Acid Bacteria: Bioactive Peptide Decrypting from Caseins and Bacteriocin Production. Microorganisms 2020;9:E65. [PMID: 33383704 DOI: 10.3390/microorganisms9010065] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
19 Yang S, Lin C, Aljuffali IA, Fang J. Current pathogenic Escherichia coli foodborne outbreak cases and therapy development. Arch Microbiol 2017;199:811-25. [DOI: 10.1007/s00203-017-1393-y] [Cited by in Crossref: 70] [Cited by in F6Publishing: 49] [Article Influence: 14.0] [Reference Citation Analysis]
20 Bury S, Soundararajan M, Bharti R, von Bünau R, Förstner KU, Oelschlaeger TA. The Probiotic Escherichia coli Strain Nissle 1917 Combats Lambdoid Bacteriophages stx and λ. Front Microbiol 2018;9:929. [PMID: 29896160 DOI: 10.3389/fmicb.2018.00929] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 1.5] [Reference Citation Analysis]
21 Ramstad SN, Taxt AM, Naseer U, Wasteson Y, Bjørnholt JV, Brandal LT. Effects of antimicrobials on Shiga toxin production in high-virulent Shiga toxin-producing Escherichia coli. Microb Pathog 2021;152:104636. [PMID: 33242644 DOI: 10.1016/j.micpath.2020.104636] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
22 Yin S, Rusconi B, Sanjar F, Goswami K, Xiaoli L, Eppinger M, Dudley EG. Escherichia coli O157:H7 strains harbor at least three distinct sequence types of Shiga toxin 2a-converting phages. BMC Genomics 2015;16:733. [PMID: 26416807 DOI: 10.1186/s12864-015-1934-1] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 3.3] [Reference Citation Analysis]
23 Rojas-Lopez M, Martinelli M, Brandi V, Jubelin G, Polticelli F, Soriani M, Pizza M, Desvaux M, Rosini R. Identification of lipid A deacylase as a novel, highly conserved and protective antigen against enterohemorrhagic Escherichia coli. Sci Rep 2019;9:17014. [PMID: 31745113 DOI: 10.1038/s41598-019-53197-z] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
24 Liu Y, Tian S, Thaker H, Dong M. Shiga Toxins: An Update on Host Factors and Biomedical Applications. Toxins (Basel) 2021;13:222. [PMID: 33803852 DOI: 10.3390/toxins13030222] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
25 Sapountzis P, Segura A, Desvaux M, Forano E. An Overview of the Elusive Passenger in the Gastrointestinal Tract of Cattle: The Shiga Toxin Producing Escherichia coli. Microorganisms 2020;8:E877. [PMID: 32531983 DOI: 10.3390/microorganisms8060877] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
26 Surendran-nair M, Kollanoor-johny A, Ananda-baskaran S, Norris C, Lee J, Venkitanarayanan K. Selenium reduces enterohemorrhagic Escherichia coli O157:H7 verotoxin production and globotriaosylceramide receptor expression on host cells. Future Microbiology 2016;11:745-56. [DOI: 10.2217/fmb.16.16] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
27 Reddy KC, Dunbar TL, Nargund AM, Haynes CM, Troemel ER. The C. elegans CCAAT-Enhancer-Binding Protein Gamma Is Required for Surveillance Immunity. Cell Rep 2016;14:1581-9. [PMID: 26876169 DOI: 10.1016/j.celrep.2016.01.055] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
28 Garcia-Angulo VA, Kalita A, Torres AG. Advances in the development of enterohemorrhagic Escherichia coli vaccines using murine models of infection. Vaccine 2013;31:3229-35. [PMID: 23707170 DOI: 10.1016/j.vaccine.2013.05.013] [Cited by in Crossref: 35] [Cited by in F6Publishing: 30] [Article Influence: 3.9] [Reference Citation Analysis]
29 Johanns VC, Epping L, Semmler T, Ghazisaeedi F, Lübke-Becker A, Pfeifer Y, Eichhorn I, Merle R, Bethe A, Walther B, Wieler LH. High-Zinc Supplementation of Weaned Piglets Affects Frequencies of Virulence and Bacteriocin Associated Genes Among Intestinal Escherichia coli Populations. Front Vet Sci 2020;7:614513. [PMID: 33392299 DOI: 10.3389/fvets.2020.614513] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
30 Zini G, De Cristofaro R. Diagnostic Testing for Differential Diagnosis in Thrombotic Microangiopathies. Turk J Haematol 2019;36:222-9. [PMID: 31337190 DOI: 10.4274/tjh.galenos.2019.2019.0165] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
31 Nakamura K, Murase K, Sato MP, Toyoda A, Itoh T, Mainil JG, Piérard D, Yoshino S, Kimata K, Isobe J, Seto K, Etoh Y, Narimatsu H, Saito S, Yatsuyanagi J, Lee K, Iyoda S, Ohnishi M, Ooka T, Gotoh Y, Ogura Y, Hayashi T. Differential dynamics and impacts of prophages and plasmids on the pangenome and virulence factor repertoires of Shiga toxin-producing Escherichia coli O145:H28. Microb Genom 2020;6. [PMID: 31935184 DOI: 10.1099/mgen.0.000323] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 5.5] [Reference Citation Analysis]
32 Ghanbarpour R, Kiani M. Characterization of non-O157 shiga toxin-producing Escherichia coli isolates from healthy fat-tailed sheep in southeastern of Iran. Trop Anim Health Prod 2013;45:641-8. [PMID: 23015355 DOI: 10.1007/s11250-012-0271-5] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
33 Khalil RK, Skinner C, Patfield S, He X. Phage-mediated Shiga toxin (Stx) horizontal gene transfer and expression in non-Shiga toxigenic Enterobacter and Escherichia coli strains. Pathog Dis 2016;74:ftw037. [PMID: 27109772 DOI: 10.1093/femspd/ftw037] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 3.7] [Reference Citation Analysis]
34 Ferreira MR, Freitas Filho EG, Pinto JF, Dias M, Moreira CN. Isolation, prevalence, and risk factors for infection by shiga toxin-producing Escherichia coli (STEC) in dairy cattle. Trop Anim Health Prod 2014;46:635-9. [PMID: 24510196 DOI: 10.1007/s11250-014-0541-5] [Cited by in Crossref: 15] [Cited by in F6Publishing: 9] [Article Influence: 1.9] [Reference Citation Analysis]
35 De Nisco NJ, Rivera-Cancel G, Orth K. The Biochemistry of Sensing: Enteric Pathogens Regulate Type III Secretion in Response to Environmental and Host Cues. mBio 2018;9:e02122-17. [PMID: 29339429 DOI: 10.1128/mBio.02122-17] [Cited by in Crossref: 16] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
36 EFSA Panel on Biological Hazards (BIOHAZ). Statement on the update of the list of QPS‐recommended biological agents intentionally added to food or feed as notified to EFSA 1: Suitability of taxonomic units notified to EFSA until October 2014. EFS2 2014;12. [DOI: 10.2903/j.efsa.2014.3938] [Cited by in Crossref: 15] [Cited by in F6Publishing: 5] [Article Influence: 1.9] [Reference Citation Analysis]
37 Sy BM, Tree JJ. Small RNA Regulation of Virulence in Pathogenic Escherichia coli. Front Cell Infect Microbiol 2020;10:622202. [PMID: 33585289 DOI: 10.3389/fcimb.2020.622202] [Reference Citation Analysis]
38 Biernbaum EN, Kudva IT. AB5 Enterotoxin-Mediated Pathogenesis: Perspectives Gleaned from Shiga Toxins. Toxins (Basel) 2022;14:62. [PMID: 35051039 DOI: 10.3390/toxins14010062] [Reference Citation Analysis]
39 Pacheco AR, Lazarus JE, Sit B, Schmieder S, Lencer WI, Blondel CJ, Doench JG, Davis BM, Waldor MK. CRISPR Screen Reveals that EHEC's T3SS and Shiga Toxin Rely on Shared Host Factors for Infection. mBio 2018;9:e01003-18. [PMID: 29921669 DOI: 10.1128/mBio.01003-18] [Cited by in Crossref: 31] [Cited by in F6Publishing: 20] [Article Influence: 7.8] [Reference Citation Analysis]
40 Philipson CW, Bassaganya-Riera J, Hontecillas R. Animal models of enteroaggregative Escherichia coli infection. Gut Microbes 2013;4:281-91. [PMID: 23680797 DOI: 10.4161/gmic.24826] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 1.9] [Reference Citation Analysis]
41 Jessurun J. The Differential Diagnosis of Acute Colitis: Clues to a Specific Diagnosis. Surg Pathol Clin. 2017;10:863-885. [PMID: 29103537 DOI: 10.1016/j.path.2017.07.008] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
42 Yang X, Wu Y, Liu Q, Sun H, Luo M, Xiong Y, Matussek A, Hu B, Bai X. Genomic Characteristics of Stx2e-Producing Escherichia coli Strains Derived from Humans, Animals, and Meats. Pathogens 2021;10:1551. [PMID: 34959506 DOI: 10.3390/pathogens10121551] [Reference Citation Analysis]
43 Rojas-Lopez M, Monterio R, Pizza M, Desvaux M, Rosini R. Intestinal Pathogenic Escherichia coli: Insights for Vaccine Development. Front Microbiol 2018;9:440. [PMID: 29615989 DOI: 10.3389/fmicb.2018.00440] [Cited by in Crossref: 32] [Cited by in F6Publishing: 29] [Article Influence: 8.0] [Reference Citation Analysis]
44 Yang SC, Hung CF, Aljuffali IA, Fang JY. The roles of the virulence factor IpaB in Shigella spp. in the escape from immune cells and invasion of epithelial cells. Microbiol Res 2015;181:43-51. [PMID: 26640051 DOI: 10.1016/j.micres.2015.08.006] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 2.6] [Reference Citation Analysis]
45 Baskaran SA, Kollanoor-johny A, Nair MS, Venkitanarayanan K. Efficacy of Plant-Derived Antimicrobials in Controlling Enterohemorrhagic Escherichia coli Virulence In Vitro. Journal of Food Protection 2016;79:1965-70. [DOI: 10.4315/0362-028x.jfp-16-104] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
46 Ruano-Gallego D, Yara DA, Di Ianni L, Frankel G, Schüller S, Fernández LÁ. A nanobody targeting the translocated intimin receptor inhibits the attachment of enterohemorrhagic E. coli to human colonic mucosa. PLoS Pathog 2019;15:e1008031. [PMID: 31465434 DOI: 10.1371/journal.ppat.1008031] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
47 Koeppel MB, Glaser J, Baumgartner T, Spriewald S, Gerlach RG, von Armansperg B, Leong JM, Stecher B. Scalable Reporter Assays to Analyze the Regulation of stx2 Expression in Shiga Toxin-Producing Enteropathogens. Toxins (Basel) 2021;13:534. [PMID: 34437405 DOI: 10.3390/toxins13080534] [Reference Citation Analysis]
48 Cordonnier C, Thévenot J, Etienne-Mesmin L, Alric M, Livrelli V, Blanquet-Diot S. Probiotic and enterohemorrhagic Escherichia coli: An effective strategy against a deadly enemy? Crit Rev Microbiol 2017;43:116-32. [PMID: 27798976 DOI: 10.1080/1040841X.2016.1185602] [Cited by in Crossref: 9] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
49 Bhatwalkar SB, Gound SS, Mondal R, Srivastava RK, Anupam R. Anti-biofilm and Antibacterial Activity of Allium sativum Against Drug Resistant Shiga-Toxin Producing Escherichia coli (STEC) Isolates from Patient Samples and Food Sources. Indian J Microbiol 2019;59:171-9. [PMID: 31031431 DOI: 10.1007/s12088-019-00784-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.7] [Reference Citation Analysis]
50 Yin F, Zhu Y, Koutchma T, Gong J. Inactivation and potential reactivation of pathogenic Escherichia coli O157:H7 in bovine milk exposed to three monochromatic ultraviolet UVC lights. Food Microbiology 2015;49:74-81. [DOI: 10.1016/j.fm.2015.01.014] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
51 Ricci A, Allende A, Bolton D, Chemaly M, Davies R, Girones R, Koutsoumanis K, Lindqvist R, Nørrung B, Robertson L, Ru G, Fernandez Escamez PS, Sanaa M, Simmons M, Skandamis P, Snary E, Speybroeck N, Ter Kuile B, Threlfall J, Wahlström H, Cocconcelli PS, Peixe L, Maradona MP, Querol A, Suarez JE, Sundh I, Vlak J, Correia S, Herman L; EFSA Panel on Biological Hazards (BIOHAZ). Update of the list of QPS-recommended biological agents intentionally added to food or feed as notified to EFSA 6: suitability of taxonomic units notified to EFSA until March 2017. EFSA J 2017;15:e04884. [PMID: 32625549 DOI: 10.2903/j.efsa.2017.4884] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 2.4] [Reference Citation Analysis]
52 Iannino F, Herrmann CK, Roset MS, Briones G. Development of a dual vaccine for prevention of Brucella abortus infection and Escherichia coli O157:H7 intestinal colonization. Vaccine 2015;33:2248-53. [DOI: 10.1016/j.vaccine.2015.03.033] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.9] [Reference Citation Analysis]
53 Tsai CE, Yang FJ, Lee CH, Hsueh YP, Kuo CJ, Chen CS. The conserved regulator of autophagy and innate immunity hlh-30/TFEB mediates tolerance of enterohemorrhagic Escherichia coli in Caenorhabditis elegans. Genetics 2021;217:1-17. [PMID: 33683370 DOI: 10.1093/genetics/iyaa052] [Reference Citation Analysis]
54 Rund SA, Rohde H, Sonnenborn U, Oelschlaeger TA. Antagonistic effects of probiotic Escherichia coli Nissle 1917 on EHEC strains of serotype O104:H4 and O157:H7. International Journal of Medical Microbiology 2013;303:1-8. [DOI: 10.1016/j.ijmm.2012.11.006] [Cited by in Crossref: 36] [Cited by in F6Publishing: 34] [Article Influence: 4.0] [Reference Citation Analysis]
55 Slater SL, Frankel G. Advances and Challenges in Studying Type III Secretion Effectors of Attaching and Effacing Pathogens. Front Cell Infect Microbiol 2020;10:337. [PMID: 32733819 DOI: 10.3389/fcimb.2020.00337] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
56 Paquette SJ, Zaheer R, Stanford K, Thomas J, Reuter T. Competition among Escherichia coli Strains for Space and Resources. Vet Sci 2018;5:E93. [PMID: 30400157 DOI: 10.3390/vetsci5040093] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
57 Ramstad SN, Wasteson Y, Lindstedt BA, Taxt AM, Bjørnholt JV, Brandal LT, Bohlin J. Characterization of Shiga Toxin 2a Encoding Bacteriophages Isolated From High-Virulent O145:H25 Shiga Toxin-Producing Escherichia coli. Front Microbiol 2021;12:728116. [PMID: 34566932 DOI: 10.3389/fmicb.2021.728116] [Reference Citation Analysis]
58 Paquette SJ, Reuter T. Escherichia coli: Physiological Clues Which Turn On the Synthesis of Antimicrobial Molecules. Vet Sci 2020;7:E184. [PMID: 33233401 DOI: 10.3390/vetsci7040184] [Reference Citation Analysis]
59 Tiku V, Kew C, Mehrotra P, Ganesan R, Robinson N, Antebi A. Nucleolar fibrillarin is an evolutionarily conserved regulator of bacterial pathogen resistance. Nat Commun 2018;9:3607. [PMID: 30190478 DOI: 10.1038/s41467-018-06051-1] [Cited by in Crossref: 21] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
60 Allué-Guardia A, Koenig SSK, Martinez RA, Rodriguez AL, Bosilevac JM, Feng P, Eppinger M. Pathogenomes and variations in Shiga toxin production among geographically distinct clones of Escherichia coli O113:H21. Microb Genom 2022;8. [PMID: 35394418 DOI: 10.1099/mgen.0.000796] [Reference Citation Analysis]
61 Sauder AB, Kendall MM. After the Fact(or): Posttranscriptional Gene Regulation in Enterohemorrhagic Escherichia coli O157:H7. J Bacteriol 2018;200:e00228-18. [PMID: 29967119 DOI: 10.1128/JB.00228-18] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
62 Fu Q, Li S, Wang Z, Shan W, Ma J, Cheng Y, Wang H, Yan Y, Sun J. H-NS Mutation-Mediated CRISPR-Cas Activation Inhibits Phage Release and Toxin Production of Escherichia coli Stx2 Phage Lysogen. Front Microbiol 2017;8:652. [PMID: 28458663 DOI: 10.3389/fmicb.2017.00652] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
63 Im H, Hwang SH, Kim BS, Choi SH. Pathogenic potential assessment of the Shiga toxin-producing Escherichia coli by a source attribution-considered machine learning model. Proc Natl Acad Sci U S A 2021;118:e2018877118. [PMID: 33986113 DOI: 10.1073/pnas.2018877118] [Reference Citation Analysis]
64 Enciso-martínez Y, González-aguilar GA, Martínez-téllez MA, González-pérez CJ, Valencia-rivera DE, Barrios-villa E, Ayala-zavala JF. Relevance of tracking the diversity of Escherichia coli pathotypes to reinforce food safety. International Journal of Food Microbiology 2022;374:109736. [DOI: 10.1016/j.ijfoodmicro.2022.109736] [Reference Citation Analysis]
65 Feitz WJC, Bouwmeester R, van der Velden TJAM, Goorden S, Licht C, van den Heuvel LPJW, van de Kar NCAJ. The Shiga Toxin Receptor Globotriaosylceramide as Therapeutic Target in Shiga Toxin E. coli Mediated HUS. Microorganisms 2021;9:2157. [PMID: 34683478 DOI: 10.3390/microorganisms9102157] [Reference Citation Analysis]
66 March Rosselló GA, Eiros Bouza JM. [Quorum sensing in bacteria and yeast]. Med Clin (Barc) 2013;141:353-7. [PMID: 23622893 DOI: 10.1016/j.medcli.2013.02.031] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
67 Nowicki D, Maciąg-Dorszyńska M, Kobiela W, Herman-Antosiewicz A, Węgrzyn A, Szalewska-Pałasz A, Węgrzyn G. Phenethyl isothiocyanate inhibits shiga toxin production in enterohemorrhagic Escherichia coli by stringent response induction. Antimicrob Agents Chemother 2014;58:2304-15. [PMID: 24492371 DOI: 10.1128/AAC.02515-13] [Cited by in Crossref: 16] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
68 Yang J, Tang CB, Xiao J, Du WF, Li R. Influences of epigallocatechin gallate and citric acid on Escherichia coli O157:H7 toxin gene expression and virulence-associated stress response. Lett Appl Microbiol 2018;67:435-41. [PMID: 30066955 DOI: 10.1111/lam.13058] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
69 Keir LS, Langman CB. Complement and the kidney in the setting of Shiga-toxin hemolytic uremic syndrome, organ transplantation, and C3 glomerulonephritis. Transfus Apher Sci 2016;54:203-11. [PMID: 27156109 DOI: 10.1016/j.transci.2016.04.010] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
70 Lynnes T, Prüss BM, Samanta P. Acetate metabolism and Escherichia coli biofilm: new approaches to an old problem. FEMS Microbiol Lett 2013;344:95-103. [PMID: 23651469 DOI: 10.1111/1574-6968.12174] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
71 Tse CM, In JG, Yin J, Donowitz M, Doucet M, Foulke-Abel J, Ruiz-Perez F, Nataro JP, Zachos NC, Kaper JB, Kovbasnjuk O. Enterohemorrhagic E. coli (EHEC)-Secreted Serine Protease EspP Stimulates Electrogenic Ion Transport in Human Colonoid Monolayers. Toxins (Basel) 2018;10:E351. [PMID: 30200426 DOI: 10.3390/toxins10090351] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
72 Howard-Varona C, Vik DR, Solonenko NE, Li YF, Gazitua MC, Chittick L, Samiec JK, Jensen AE, Anderson P, Howard-Varona A, Kinkhabwala AA, Abedon ST, Sullivan MB. Fighting Fire with Fire: Phage Potential for the Treatment of E. coli O157 Infection. Antibiotics (Basel) 2018;7:E101. [PMID: 30453470 DOI: 10.3390/antibiotics7040101] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
73 Jubelin G, Desvaux M, Schüller S, Etienne-Mesmin L, Muniesa M, Blanquet-Diot S. Modulation of Enterohaemorrhagic Escherichia coli Survival and Virulence in the Human Gastrointestinal Tract. Microorganisms 2018;6:E115. [PMID: 30463258 DOI: 10.3390/microorganisms6040115] [Cited by in Crossref: 16] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
74 Long J, Geng J, Xu Y, Jin Y, Yang H, Xi Y, Chen S, Duan G. Large-Scale Phylogenetic Analysis Reveals a New Genetic Clade among Escherichia coli O26 Strains. Microbiol Spectr 2022;:e0252521. [PMID: 35107330 DOI: 10.1128/spectrum.02525-21] [Reference Citation Analysis]
75 Cabrera G, Fernández-Brando RJ, Mejías MP, Ramos MV, Abrey-Recalde MJ, Vanzulli S, Vermeulen M, Palermo MS. Leukotriene C4 increases the susceptibility of adult mice to Shiga toxin-producing Escherichia coli infection. Int J Med Microbiol 2015;305:910-7. [PMID: 26456732 DOI: 10.1016/j.ijmm.2015.09.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
76 Cheng C, Balasubramanian S, Fekete A, Krischke M, Mueller MJ, Hentschel U, Oelschlaeger TA, Abdelmohsen UR. Inhibitory potential of strepthonium A against Shiga toxin production in enterohemorrhagic Escherichia coli (EHEC) strain EDL933. Natural Product Research 2017;31:2818-23. [DOI: 10.1080/14786419.2017.1297443] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]